エーザイ、「レンビマ(R)」(レンバチニブ)と「キイトルーダ(R)」(ペムブロリズマブ)の併用療法について2つの臨床試験から7種のがんに対する初めての臨床データを欧州臨床腫瘍学会年次総会において発表 Eisai Sep 23, 2020 09:00 JST Read More
Eisai Receives Positive Opinion from EMA's CHMP on Use of Antiepileptic Agent Fycompa in Pediatric Patients Eisai Sep 23, 2020 08:24 HKT/SGT Read More
Eisai and Merck Present First-Time Data From Two Studies Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020 Eisai Sep 23, 2020 08:10 HKT/SGT Read More
AIM ImmunoTech從荷蘭鹿特丹伊拉斯姆斯大學醫學中心 獲得胰腺癌的統計學上顯著的陽性存活結果 AIM ImmunoTech Inc Sep 23, 2020 07:00 HKT/SGT Read More
AIM ImmunoTech、オランダ・ロッテルダムのエラスムス大学医療センターより膵臓癌で統計的に有意な陽性の生存率を得る AIM ImmunoTech Inc Sep 23, 2020 07:00 JST Read More
AIM ImmunoTech从荷兰鹿特丹伊拉斯姆斯大学医学中心 获得胰腺癌的统计学上显著的阳性存活结果 AIM ImmunoTech Inc Sep 23, 2020 07:00 HKT/SGT Read More
아방스 클리니컬, 바이오팜 아메리카에서 생명공학 임상시험을 위한 전자임상시험 솔루션 확대 발표 Avance Clinical Sep 22, 2020 18:00 HKT/SGT Read More
Avance Clinical宣佈為美國BioPharm的生物技術臨床試驗研究 擴大電子臨床解決方案 Avance Clinical Sep 22, 2020 10:00 HKT/SGT Read More
Avance Clinical宣布为美国BioPharm的生物技术临床试验研究 扩大电子临床解决方案 Avance Clinical Sep 22, 2020 10:00 HKT/SGT Read More
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America Avance Clinical Sep 22, 2020 07:50 HKT/SGT Read More
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance Document Security Systems, Inc Sep 18, 2020 17:00 HKT/SGT Read More
エーザイ、抗がん剤「ハラヴェン(R)」(エリブリン)リポソーム製剤の臨床第I相試験の最新データを欧州臨床腫瘍学会年次総会において発表 Eisai Sep 18, 2020 12:00 JST Read More
Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020 Eisai Sep 18, 2020 10:29 HKT/SGT Read More
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development Dyadic International, Inc. Sep 17, 2020 20:30 HKT/SGT Read More
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19 NanoViricides, Inc. Sep 16, 2020 18:15 HKT/SGT Read More